Status:
COMPLETED
Glucagon Like Peptide 1 (GLP-1) Booster™ RCT Study
Lead Sponsor:
Lawry Han
Conditions:
Blood Sugar; High
Overweight and Obesity
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
BACKGROUND GLP1 booster (GB) was designed to stimulate the endogenous production of GLP1, which in turn releases insulin, controls blood glucose level, suppresses appetite and thus helps people lose w...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Volunteers must be over the age of 18.
- Volunteers cannot be smokers.
- Volunteers cannot be currently taking a dietary supplement or prescription for weight loss.
- Exercising volunteers must maintain their regimen consistently throughout the course of the 26-week study.
- Caffeine drinking volunteers must maintain their caffeine intake consistently throughout the course of the 26-week study.
- Volunteers need to be overweight but not obese, as defined by having a BMI between 25.0 and 29.9
Exclusion
Key Trial Info
Start Date :
January 7 2025
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 14 2025
Estimated Enrollment :
69 Patients enrolled
Trial Details
Trial ID
NCT07141472
Start Date
January 7 2025
End Date
August 14 2025
Last Update
September 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Alpine Bio
Salt Lake City, Utah, United States, 84108